Thu, October 5, 2023
Wed, October 4, 2023
Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023

Gavin Clark-Gartner Initiated (ACRS) at Buy and Held Target at $22 on, Oct 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-22-on-oct-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gavin Clark-Gartner of Evercore ISI Group, Initiated "Aclaris Therapeutics, Inc." (ACRS) at Buy and Held Target at $22 on, Oct 3rd, 2023.

Gavin has made no other calls on ACRS in the last 4 months.



There are 3 other peers that have a rating on ACRS. Out of the 3 peers that are also analyzing ACRS, 0 agree with Gavin's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Gavin


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $38 on, Tuesday, September 19th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Tuesday, September 19th, 2023
  • Alex Thompson of "Stifel" Maintained at Strong Buy with Increased Target to $20 on, Thursday, September 14th, 2023

Publication Contributing Sources